LESLIE P. WEINER, M.D.
Neurology at San Pablo St, Los Angeles, CA
License number
California G31428
Category
Neurology
Type
Neurology
Address
Address
1520 San Pablo St SUITE 3000, Los Angeles, CA 90033
Phone
(323) 442-5710
(323) 442-5729 (Fax)
(323) 442-5729 (Fax)
Personal information
See more information about LESLIE P. WEINER at radaris.comName
Address
Phone
2800 Joseph Ave APT 2, Campbell, CA 95008
625 S Rimpau Blvd, Los Angeles, CA 90005
1929 Ruhland Ave APT B, Redondo Beach, CA 90278
1929 Ruhland Ave, Redondo Beach, CA 90278
1500 San Pablo St, Los Angeles, CA 90033
Organization information
See more information about LESLIE P. WEINER at bizstanding.comLeslie P Weiner Neurologic Care
1520 San Pablo St, Los Angeles, CA 90033
Industry:
Neurologist
Phone:
(323) 442-5710 (Phone)
Description:
There are 24 doctors at this site. Surgery is not performed at this site. Average patient volume is 60 patients per day.
LESLIE P. WEINER, M.D., INC
625 S Rimpau, Los Angeles, CA 90005
Status:
Inactive
Doing business as:
Leslie P Weiner MD
Registration:
Dec 17, 1982
Phone:
(323) 442-3020 (Phone)
State ID:
C1164978
Business type:
Articles of Incorporation
Neurologys:
Carol M. Cleary (Neurology),Laura A. Kalayjian (Neurology),Helena C. Chui (Neurology),...
Agent:
Leslie P Weiner,Los Angeles, CA 90005 (Physical)
Leslie P. Weiner, M.D., Inc., A California Professional Corporation; Leslie P. Weiner, President
2025 Zonal Ave, Los Angeles, CA 90089
Status:
Inactive
Member:
University Of Southern California Neurologists, A California Limited Partnership (Member)
Professional information
Dr. Leslie P Weiner - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Certifications:
Neurology, 1969
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
USC Neurology
1520 San Pablo St SUITE 3000, Los Angeles 90033
Keck Medical Center at USC
1500 San Pablo St, Los Angeles 90033
USC Neurology
1520 San Pablo St SUITE 3000, Los Angeles 90033
Keck Medical Center at USC
1500 San Pablo St, Los Angeles 90033
1520 San Pablo St SUITE 3000, Los Angeles 90033
Keck Medical Center at USC
1500 San Pablo St, Los Angeles 90033
USC Neurology
1520 San Pablo St SUITE 3000, Los Angeles 90033
Keck Medical Center at USC
1500 San Pablo St, Los Angeles 90033
Education:
Medical School
University Of Cincinnati College Of Medicine
Graduated: 1961
SUNY Upstate Med Center
Graduated: 1962
Baltimore City Hospital
Graduated: 1963
Johns Hopkins Hospital
Graduated: 1965
Johns Hopkins School Med
Graduated: 1969
University Of Cincinnati College Of Medicine
Graduated: 1961
SUNY Upstate Med Center
Graduated: 1962
Baltimore City Hospital
Graduated: 1963
Johns Hopkins Hospital
Graduated: 1965
Johns Hopkins School Med
Graduated: 1969
Construction And Use Of Genes Encoding Pathogenic Epitopes For Treatment Of Autoimmune Disease
US Patent:
2002014, Oct 3, 2002
Filed:
Mar 14, 2002
Appl. No.:
10/098035
Inventors:
Leslie Weiner - Los Angeles CA, US
Minnie McMillan - Los Angeles CA, US
Minnie McMillan - Los Angeles CA, US
Assignee:
University of southern California
International Classification:
A61K048/00
US Classification:
424/093210
Abstract:
The present invention relates to the application of genetic engineering to provide a treatment of autoimmune disease. This is achieved preferably through the introduction of one or more recombinant genes encoding self antigens which are the target of an autoimmune response. In particular the invention provides a method of designing and constructing a gene encoding an encephalitogenic epitope of proteolipid protein, and to the in vivo expression of the gene product by a recombinant retroviral vector. The expression and secretion of the encephalitogenic epitope ameliorates the histopathological and clinical characteristics of experimental autoimmune encephalomyelitis (EAE) in the mouse model for multiple sclerosis (MS).
Construction And Use Of Genes Encoding Pathogenic Epitopes For Treatment Of Autoimmune Disease
US Patent:
2004007, Apr 15, 2004
Filed:
Feb 5, 2003
Appl. No.:
10/359397
Inventors:
Leslie Weiner - Los Angeles CA, US
Minnie McMillan - Bradbury, GB
Minnie McMillan - Bradbury, GB
International Classification:
A61K048/00
US Classification:
424/093210
Abstract:
The present invention relates to the application of genetic engineering to provide a treatment of autoimmune disease. This is achieved preferably through the introduction of one or more recombinant genes encoding self antigens which are the target of an autoimmune response. In particular the invention provides a method of designing and constructing a gene encoding an encephalitogenic epitope of proteolipid protein, and to the in vivo expression of the gene product by a recombinant retroviral vector. The expression and secretion of the encephalitogenic epitope ameliorates the histopathological and clinical characteristics of experimental autoimmune encephalomyelitis (EAE) in the mouse model for multiple sclerosis (MS).
Construction And Use Of Genes Encoding Pathogenic Epitopes For Treatment Of Autoimmune Disease
US Patent:
6274136, Aug 14, 2001
Filed:
May 29, 1996
Appl. No.:
8/654737
Inventors:
Leslie P. Weiner - Los Angeles CA
Minnie McMillan - Bradbury CA
Minnie McMillan - Bradbury CA
Assignee:
University of Southern California - Los Angeles CA
International Classification:
A61K 4800, C12N 1500, C12N 700
US Classification:
424 9321
Abstract:
The present invention relates to the application of genetic engineering to provide a treatment of autoimmune disease. This is achieved preferably through the introduction of one or more recombinant genes encoding self antigens which are the target of an autoimmune response. In particular the invention provides a method of designing and constructing a gene encoding an encephalogenic epitope of proteolipid protein, and to the in vivo expression of the gene product by a recombinant retroviral vector. The expression and secretion of the encephalogenic epitope ameliorates the histopathological and clinical characteristics of experimental autoimmune encephalomyelitis (EAE) in the mouse model for multiple sclerosis (MS).
Construction And Use Of Genes Encoding Pathogenic Epitopes For Treatment Of Autoimmune Disease
US Patent:
8323963, Dec 4, 2012
Filed:
Jul 17, 2006
Appl. No.:
11/488524
Inventors:
Leslie P. Weiner - Los Angeles CA, US
Minnie McMillan - Bradbury CA, US
Minnie McMillan - Bradbury CA, US
Assignee:
University of Southern California - Los Angeles CA
International Classification:
C12N 5/10, A61K 48/00
US Classification:
435325, 435357, 424 9321
Abstract:
This invention relates to the design and construction of a gene encoding an encephalogenic epitope of proteolipid protein (PLP), design and construction of a gene encoding an encephalogenic epitope of myelin based protein (MBP), to methods of expression of a PLP epitope, to methods of expression of a MBP epitope, to methods of in vivo secretion of a PLP epitope, and to methods of transferring the partial PLP gene to a host to ameliorate the progression of an immune response to self antigens derived from myelin proteins, to methods of in vivo secretion of a MBP epitope, and to methods of transferring the partial MBP gene to a host to ameliorate the progression of an immune response to self antigens derived from myelin proteins.
Professor At University Of Southern California
Position:
Professor at University of Southern California
Location:
Greater Los Angeles Area
Industry:
Research
Work:
University of Southern California
-
Professor
Education:
Wilkes University 1953 - 1957
Leslie Philip Weiner, Los Angeles CA
Specialties:
Neurology, Cardiovascular Disease, Cardiology
Work:
University of Southern California
2025 Zonal Ave, Los Angeles, CA 90089 Usc
1520 San Pablo St, Los Angeles, CA 90033
2025 Zonal Ave, Los Angeles, CA 90089 Usc
1520 San Pablo St, Los Angeles, CA 90033
Education:
University of Cincinnati (1961)
T-Cell Vaccination For The Treatment Of Multiple Sclerosis
US Patent:
2004015, Aug 12, 2004
Filed:
Feb 5, 2004
Appl. No.:
10/773356
Inventors:
Leslie Weiner - Los Angeles CA, US
Jorge Correale - Buenos Aires, AR
Jorge Correale - Buenos Aires, AR
International Classification:
A61K039/00
US Classification:
424/185100
Abstract:
Disclosed are methods and compositions useful for the treatment of autoimmune diseases. Methods for producing vaccines against autoreactive T-cells are disclosed. The vaccines so produced are capable of restoring a degree of immunologic self-tolerance sufficient to slow or halt the progression of autoimmune disorders. In a preferred embodiment of the invention, a vaccine is derived from attenuated autologous autoreactive T-cells that recognize a variety of myelin-derived proteins. Such vaccine compositions are useful for immunologic therapy for the treatment of multiple sclerosis (MS).
T-Cell Vaccination For The Treatment Of Multiple Sclerosis
US Patent:
2002000, Jan 24, 2002
Filed:
Sep 17, 1998
Appl. No.:
09/156509
Inventors:
LESLIE P. WEINER - LOS ANGELES CA, US
JORGE D. CORREALE - BUENOS AIRES, AR
JORGE D. CORREALE - BUENOS AIRES, AR
International Classification:
A61K039/395, A61K039/38
US Classification:
424/154100, 424/184100, 424/810000
Abstract:
Disclosed are methods and compositions useful for the treatment of autoimmune diseases. Methods for producing vaccines against autoreactive T-cells are disclosed. The vaccines so produced are capable of restoring a degree of immunologic self-tolerance sufficient to slow or halt the progression of autoimmune disorders. In a preferred embodiment of the invention, a vaccine is derived from attenuated autologous autoreactive T-cells that recognize a variety of myelin-derived proteins. Such vaccine compositions are useful for immunologic therapy for the treatment of multiple sclerosis (MS).
Neurology licenses in California
ROBERT MICHAEL HUTCHMAN, M.D., INC., Neurology, 19231 Victory Blvd SUITE 355N, Los Angeles, CA 91335